Earnings Q3 FY26 | February 17, 2025 Contact: investor.relations@medtronic.com Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation, geopolitical conflicts, changing global trade polic ...

Core Insights - Inspira Technologies announced a strategic commercial showcase of its FDA-cleared INSPIRA™ ART100 system at the AmSECT 64th International Conference, scheduled for March 25–29, 2026, in Austin, Texas [1][4] Group 1: Commercial Strategy - The showcase aims to engage directly with decision-makers in hospitals, enhancing the company's U.S. commercial strategy and expanding clinical partnerships and distribution [3][7] - The ART100 system has received FDA 510(k) clearance, validating its readiness for clinical integration in cardiopulmonary bypass procedures [7] Group 2: Product Overview - The INSPIRA™ ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., serving as a foundation for the development of the next-generation INSPIRA ART500 system [5] - The company is also advancing the HYLA™ blood sensor platform, which offers continuous, non-invasive monitoring [5] Group 3: Industry Context - The AmSECT International Conference is a key global event for perfusion technology, featuring cutting-edge medical technologies and expert-led sessions [4]

Core Viewpoint - Medtronic reported a decline in profit during its fiscal third quarter due to rising costs and increased investments in the business, which countered the effects of higher revenue [1] Financial Performance - The company experienced a profit decrease in the fiscal third quarter, attributed to escalating costs and strategic investments [1] - Higher revenue was noted, but it was not sufficient to offset the increased expenses [1]

Medtronic plc (MDT) shares were down more than 5% in pre-market trading on Tuesday after the healthcare company reported lower third-quarter profit, primarily due to higher expenses.Net income fell to $1.143 billion, or $0.89 per share, from $1.294 billion, or $1.01 per share a year earlier. Adjusted earnings, which exclude one-time items, came in at $1.750 billion, or $1.36 per share.Operating profit decreased to $1.464 billion from $1.646 billion last year.The company's revenue for the period rose 8.7% t ...

Group 1 - Activist investor Jana Partners has acquired a stake in Fiserv and is urging the company to take actions to improve its declining share price [1] - Fiserv's shares increased by 6.5% in premarket trading following the news [1] - The company's stock has experienced a significant decline, dropping over 67% in 2025 [1]

Medtronic says it expects to take a $185 million hit from tariffs in the fiscal year. ...

Market Overview - U.S. stock futures were slightly down as markets reopened, reflecting cautious sentiment among traders after recent volatility in the tech sector related to AI [1] - Bank of America's monthly global fund manager survey indicates an "uber-bullish" sentiment among investors regarding the economy and earnings for the year, despite concerns over potential overspending on AI infrastructure [1] Economic Indicators - Japan's GDP growth for Q4 was reported at an annualized 0.2%, significantly below the forecasted 1.6% gain, impacting the yen which eased 0.4% against the dollar [1] - In the UK, unemployment rose to 5.2%, the highest level in over ten years excluding the pandemic, leading to speculation of a potential interest rate cut by the Bank of England [1] Corporate Earnings - Walmart has joined the trillion-dollar club of company valuations, now ranking as the 12th most valuable publicly listed company globally [1] - Medtronic and Palo Alto Networks are among the companies set to report earnings this week, with Medtronic already beating quarterly profit estimates due to strong demand for heart devices [2]

Group 1: Danaher and Masimo Acquisition - Danaher (DHR) is nearing a $10 billion acquisition of medical technology company Masimo (MASI), which represents a premium to Masimo's nearly $7 billion market capitalization as of last Friday's close [3][4] - The acquisition would be Danaher's largest since its $21.4 billion takeover of Cytiva in 2020 [5] - Masimo's stock has increased by 32% in premarket trading, despite a 27% decline over the past year [3][5] Group 2: Norwegian Cruise Line and Elliott Investment Management - Elliott Investment Management has acquired over a 10% stake in Norwegian Cruise Line Holdings (NCLH) to advocate for operational and strategic changes [5][6] - Norwegian Cruise Line's shares have decreased nearly 4% year-to-date, underperforming competitors like Carnival (CCL) and Royal Caribbean (RCL) [6] Group 3: Costco Lawsuit - Costco (COST) is facing a class action lawsuit alleging salmonella contamination at its Nebraska chicken processing plant [8] - The lawsuit claims that Costco's failure to control salmonella poses a danger to consumers and violates their trust [8] - Costco reported that its $4.99 rotisserie chicken sales exceeded 157 million worldwide in 2025 [9]

Core Viewpoint - Teleflex Incorporated will host a conference call on February 26, 2026, to discuss its fourth quarter 2025 financial results and provide an operational update [1] Company Information - Teleflex is a global provider of medical technologies focused on improving health and quality of life [1] - The company aims to become the most trusted partner in healthcare, offering a diverse portfolio in various therapy areas including anesthesia, emergency medicine, interventional cardiology, radiology, surgical, vascular access, and urology [1] - Teleflex's product brands include Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™, and Weck™, all united by a common purpose [1] Conference Call Details - The conference call is scheduled for 8:00 a.m. Eastern Time on February 26, 2026 [1] - Participants can pre-register for the call through a provided link and access it via a live audio webcast on the company's website [1] - An audio replay will be available starting at 11:00 a.m. Eastern Time on the same day, accessible through the Teleflex website or by telephone [1]

Core Viewpoint - The medical-device maker is anticipated to function as an independent entity within Danaher's Diagnostics segment [1] Group 1 - The company will operate as a stand-alone business, indicating a strategic focus on its specific market segment [1]